Neurelis, Inc. to Participate in the 5th Annual Evercore ISI HealthCONx Conference

SAN DIEGO, Nov. 28, 2022 /PRNewswire/ — Neurelis, Inc., a commercial-stage neuroscience company focused on the development and commercialization of therapeutics for the treatment of epilepsy and orphan neurologic disorders characterized by high unmet medical need, today announced that…

Click here to view original post